Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Nature, Published online: 23 December 2020; doi:10.1038/s41586-020-03075-w

Expression of the Epstein–Barr virus protein LMP1 in B cells increases expression of—and promotes T cell responses to—tumour-associated antigens, delineating a mechanism of infection-induced anti-tumour immunity, which could inform immune-based approaches to cancer treatment.